C diff....Again
Abstract
The AHRQ commissioned a systemic review of C diff. Bottom line....vancomycin ($1300) is probably not better than metronidazole ($20); also, fidaxomicin ($3400) appears to reduce relapse vs vancomycin for non-NAP1 strains.
Part of
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.